These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 2975203

  • 21. Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression.
    Gresele P, Corona C, Alberti P, Nenci GG.
    Thromb Haemost; 1990 Aug 13; 64(1):80-6. PubMed ID: 2274931
    [Abstract] [Full Text] [Related]

  • 22. Antiaggregatory effects of picotamide in long-term treatment: a 2-year, double-blind placebo-controlled trial.
    Cocozza M, Milani M, Picano T, Oliviero U, Russo N, Coto V.
    Vasc Med; 1997 Nov 13; 2(4):292-5. PubMed ID: 9575601
    [Abstract] [Full Text] [Related]

  • 23. Effect of nafazatrom on platelet function and release: relationship to symptomatic episodes in patients with peripheral vascular disease.
    Buchanan MR, Butt RW, Turpie AG.
    Am Heart J; 1987 May 13; 113(5):1133-7. PubMed ID: 2953219
    [Abstract] [Full Text] [Related]

  • 24. [Picotamide: prevention and therapy of diabetic vasculopathies. A double-blind clinical study].
    Pibiri L, Petruzzo P, De Giudici A, Brotzu G.
    Clin Ter; 1990 May 31; 133(4):233-7. PubMed ID: 2142911
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Effect of chuan-xiong granules on platelet aggregation, plasma beta-thromboglobulin, platelet factor IV, thromboxane B2 and 6-keto-prostaglandin F1 alpha in coronary disease patients].
    Yu Z, Chen KJ.
    Zhong Xi Yi Jie He Za Zhi; 1987 Jan 31; 7(1):8-11, 3. PubMed ID: 2954711
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Picotamide, selective inhibitor of thromboxane synthesis in patients on maintenance hemodialysis.
    Vandelli L, Grosoli M, Lusvarghi E, Cenci AM, Campioli D, Grossi G.
    Nephrol Dial Transplant; 1989 Jan 31; 4(12):1083-4. PubMed ID: 2517331
    [No Abstract] [Full Text] [Related]

  • 32. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
    Reilly IA, Doran JB, Smith B, FitzGerald GA.
    Circulation; 1986 Jun 31; 73(6):1300-9. PubMed ID: 2938849
    [Abstract] [Full Text] [Related]

  • 33. [Effects of ticlopidine on the plasma levels of beta-thromboglobulin and thromboxane B2 in types 1 and 2 diabetics].
    Gragnoli G, Signorini AM, Tanganelli I.
    Minerva Med; 1984 Jul 31; 75(30-31):1791-6. PubMed ID: 6207465
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study.
    Neri Serneri GG, Coccheri S, Marubini E, Violi F, Drug Evaluation in Atherosclerotic Vascular Disease in Diabetics (DAVID) Study Group.
    Eur Heart J; 2004 Oct 31; 25(20):1845-52. PubMed ID: 15474700
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Influence of triflusal on platelet activation after coronary artery bypass graft.
    Prieto MA, De La Cruz JP, Del Prado MF, Sánchez de la Cuesta F.
    Blood Coagul Fibrinolysis; 2000 Mar 31; 11(2):191-7. PubMed ID: 10759013
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.